Olink
  • Home
  • Products
    See our
    Complete biomarker list
    See the list
    Target 96 Panels
    • Products Overview
    • Cardiometabolic panel
    • Cell Regulation panel
    • Cardiovascular II panel
    • Cardiovascular III panel
    • Development panel
    • Immune Response panel
    • Immuno-Oncology panel
    • Inflammation panel
    • Metabolism panel
    • Neurology panel
    • Neuro Exploratory panel
    • Oncology II panel
    • Oncology III panel
    • Organ Damage panel
    • Mouse Exploratory panel
    Other Products
    • Olink Explore 1536
    • Olink Target 48 Cytokine
    • Custom panels
    • Statistical services
    • Insights Stat Analysis app
    • NPX Manager
  • Analysis Service
    • How our Analysis Service works
    • Analysis Service Uppsala
    • Analysis Service Boston
    • External service providers
  • Data you can trust
    • Publications
    • Why you can trust Olink
    • Our PEA technology
    • Data generation and QC
    • Transparent data validation
    • Customer testimonials
    • Webinars
  • Resources & support
    • Resources & support central
    • Document download center
    • White papers from Olink
    • FAQ
    • Using Olink with other sample matrices
    • Olink with other species
  • About us
    • About Olink Proteomics
    • Olink & COVID-19
    • Contact us
    • Olink Japan
    • Integrity Policy
    • News and events
    • Working at Olink
    • Our vision
    • Press releases

  • Products
  • Complete human protein biomarkers list
  • Complete human protein biomarkers list

    See all of our currently available Target 96 and Target 48 assays for human protein biomarkers

    Protein biomarkers

    The total number of different assays for human protein biomarkers currently available via our 14 human Olink® Target 96 and Olink® Target 48 panels  = 1162 – with more to come! You can browse or search this complete list here, or alternatively, see all the biomarkers available in a specific panel by going to the individual panel product page (using the links in the navigation to the left). Please note that the biomarkers for our Mouse Exploratory panel are not included in the list below – to see the details of those biomarkers, please visit the mouse panel product page. You can, however, use the search function below to look for both human and mouse biomarkers – search results are displayed in different tabs for the different species.

    June 3, 2020 – please note: For the assays included in Olink® Explore 1536 with NGS readout, please visit www.olinkexplore.com

    Protein wish list

    If you would like to suggest an assay that is not currently available in our library as an idea for future development, please use the link below to go to our wishlist suggestion form:

    More information about our protein biomarkers

    The pages for our protein biomarkers linked to below include calibrator curves that show the performance of each assay with the estimated sensitivity and dynamic range parameters indicated. These curves are generated during the assay validation process using recombinant antigens, with data presented as Normalized Protein eXpression (NPX) values plotted against protein concentration (in pg/mL). Please note that when analyzing biological samples the data generated will be given in the form of relative quantification (NPX values) and cannot be converted to absolute protein concentrations. For more info about NPX measurements, please view the FAQ.

    Nomenclature of protein biomarkers

    Note on nomenclature: where proteins have multiple synonyms, the long and short names given below are generally those recommended by Uniprot. To see all of the synonyms that may apply to a given marker, visit the Uniprot website and search using the unique Uniprot ID number listed for the protein.

    • Request a future marker
  • Search all our protein biomarkers

    • Nodal modulator 1 (NOMO1) in Metabolism panel - Q15155
    • NT-3 growth factor receptor (NTRK3) in Neurology panel - Q16288
    • Nuclear factor of activated T-cells, cytoplasmic 1 (NFATC1) in Cell Regulation panel - O95644
    • Nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3) in Immune Response panel - Q12968
    • Nucleobindin-2 (NUCB2) in Organ Damage panel - P80303
    • Nucleophosmin (NPM1) in Neuro Exploratory panel - P06748
    • Oligodendrocyte-myelin glycoprotein (OMG) in Cell Regulation panel - P23515
    • Oncostatin-M (OSM) in Inflammation panel - P13725
    • Oncostatin-M (OSM) in Olink Target 48 Cytokine - P13725
    • Oncostatin-M-specific receptor subunit beta (OSMR) in Cardiometabolic panel - Q99650
    • Opticin (OPTC) in Cell Regulation panel - Q9UBM4
    • Osteoclast-associated immunoglobulin-like receptor (hOSCAR) in Cardiovascular II panel - Q8IYS5
    • Osteomodulin (OMD) in Development panel - Q99983
    • Osteopontin (OPN) in Cardiovascular III panel - P10451
    • Osteoprotegerin (OPG) in Inflammation panel - O00300
    • Osteoprotegerin (OPG) in Cardiovascular III panel - O00300
    • OX-2 membrane glycoprotein (CD200) in Neurology panel - P41217
    • P-selectin (SELP) in Cardiovascular III panel - P16109
    • P-selectin glycoprotein ligand 1 (PSGL-1) in Cardiovascular II panel - Q14242
    • Paired immunoglobulin-like type 2 receptor alpha (PILRA) in Development panel - Q9UKJ1
    • Paired immunoglobulin-like type 2 receptor beta (PILRB) in Metabolism panel - Q9UKJ0
    • Pancreatic prohormone (PPY) in Oncology II panel - P01298
    • Pappalysin-1 (PAPPA) in Cardiovascular II panel - Q13219
    • Paraoxonase (PON3) in Cardiovascular III panel - Q15166
    • Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) in Immune Response panel - Q03431
    • Parvalbumin alpha (PVALB) in Organ Damage panel - P20472
    • Paxillin (PXN) in Organ Damage panel - P49023
    • PC4 and SFRS1-interacting protein (PSIP1) in Immune Response panel - O75475
    • Pentraxin-related protein PTX3 (PTX3) in Cardiovascular II panel - P26022
    • Peptidoglycan recognition protein 1 (PGLYRP1) in Cardiovascular III panel - O75594
    • Peptidyl-glycine alpha-amidating monooxygenase (PAM) in Cardiometabolic panel - P19021
    • Peptidyl-prolyl cis-trans isomerase B (PPIB) in Development panel - P23284
    • Peptidyl-prolyl cis-trans isomerase FKBP1B (FKBP1B) in Organ Damage panel - P68106
    • Peptidyl-prolyl cis-trans isomerase FKBP4 (FKBP4) in Metabolism panel - Q02790
    • Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP5) in Neuro Exploratory panel - Q13451
    • Peptidyl-prolyl cis-trans isomerase FKBP7 (FKBP7) in Neuro Exploratory panel - Q9Y680
    • Perilipin-1 (PLIN1) in Organ Damage panel - O60240
    • Perlecan (PLC) in Cardiovascular III panel - P98160
    • Peroxiredoxin-1 (PRDX1) in Immune Response panel - Q06830
    • Peroxiredoxin-5, mitochondrial (PRDX5) in Immune Response panel - P30044
    • Peroxiredoxin-6 (PRDX6) in Cell Regulation panel - P30041
    • peroxisomal 3-ketoacyl-CoA thiolase (ACAA1) in Oncology III panel - P09110
    • Persephin (PSPN) in Oncology III panel - O60542
    • Phosphatidylethanolamine-binding protein 1 (PEBP1) in Development panel - P30086
    • Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (INPPL1) in Organ Damage panel - O15357
    • Phosphoethanolamine/phosphocholine phosphatase (PHOSPHO1) in Neuro Exploratory panel - Q8TCT1
    • Phosphoinositide 3-kinase adapter protein 1 (PIK3AP1) in Immune Response panel - Q6ZUJ8
    • Phospholipid transfer protein (PLTP) in Cardiometabolic panel - P55058
    • Phosphomevalonate kinase (PMVK) in Neuro Exploratory panel - Q15126
    • Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in Metabolism panel - Q9NWQ8
    • Phosphoribosyltransferase domain-containing protein 1 (PRTFDC1) in Neuro Exploratory panel - Q9NRG1
    • Placenta growth factor (PGF) in Cardiovascular II panel - P49763
    • Placenta growth factor (PGF) in Immuno-Oncology panel - P49763
    • Placenta growth factor (PGF) in Organ Damage panel - P49763
    • Plasma serine protease inhibitor (SERPINA5) in Cardiometabolic panel - P05154
    • Plasminogen activator inhibitor 1 (PAI) in Cardiovascular III panel - P05121
    • Platelet endothelial aggregation receptor 1 (PEAR1) in Development panel - Q5VY43
    • Platelet endothelial cell adhesion molecule (PECAM-1) in Cardiovascular III panel - P16284
    • Platelet glycoprotein Ib alpha chain (GP1BA) in Cardiometabolic panel - P07359
    • Platelet glycoprotein VI (GP6) in Cardiovascular III panel - Q9HCN6
    • Platelet-activating factor acetylhydrolase (PLA2G7) in Cardiometabolic panel - Q13093
    • Platelet-derived growth factor C (PDGFC) in Organ Damage panel - Q9NRA1
    • Platelet-derived growth factor receptor alpha (PDGF-R-alpha) in Neurology panel - P16234
    • Platelet-derived growth factor receptor beta (PDGFRB) in Development panel - P09619
    • Platelet-derived growth factor subunit A (PDGF subunit A) in Cardiovascular III panel - P04085
    • Platelet-derived growth factor subunit B (PDGF subunit B) in Cardiovascular II panel - P01127
    • Platelet-derived growth factor subunit B (PDGF subunit B) in Immuno-Oncology panel - P01127
    • Pleiotrophin (PTN) in Immuno-Oncology panel - P21246
    • Pleiotrophin (PTN) in Organ Damage panel - P21246
    • Plexin domain-containing protein 1 (PLXDC1) in Organ Damage panel - Q8IUK5
    • Plexin-A4 (PLXNA4) in Immune Response panel - Q9HCM2
    • Plexin-B1 (PLXNB1) in Neurology panel - O43157
    • Plexin-B2 (PLXNB2) in Cardiometabolic panel - O15031
    • Plexin-B3 (PLXNB3) in Neurology panel - Q9ULL4
    • Podocalyxin (PODXL) in Oncology II panel - O00592
    • Podocalyxin-like protein 2 (PODXL2) in Cell Regulation panel - Q9NZ53
    • Poliovirus receptor (PVR) in Neurology panel - P15151
    • Poly [ADP-ribose] polymerase 1 (PARP-1) in Cardiovascular II panel - P09874
    • Polymeric immunoglobulin receptor (PIgR) in Cardiovascular II panel - P01833
    • Polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10) in Organ Damage panel - Q86SR1
    • Polypeptide N-acetylgalactosaminyltransferase 2 (GALNT2) in Cell Regulation panel - Q10471
    • Polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3) in Immune Response panel - Q14435
    • Porphobilinogen deaminase (HMBS) in Oncology III panel - P08397
    • Prefoldin subunit 2 (PFDN2) in Neuro Exploratory panel - Q9UHV9
    • Pregnancy-specific beta-1-glycoprotein 1 (PSG1) in Neuro Exploratory panel - P11464
    • Pro-cathepsin H (CTSH) in Metabolism panel - P09668
    • Pro-epidermal growth factor (EGF) in Oncology II panel - P01133
    • Pro-epidermal growth factor (EGF) in Immuno-Oncology panel - P01133
    • Pro-epidermal growth factor (EGF) in Olink Target 48 Cytokine - P01133
    • Pro-interleukin-16 (IL16) in Cardiovascular II panel - Q14005
    • Pro-neuropeptide Y (NPY) in Oncology III panel - P01303
    • Probable ATP-dependent RNA helicase DDX58 (DDX58) in Immune Response panel - O95786
    • Probable carboxypeptidase X1 (CPXM1) in Cell Regulation panel - Q96SM3
    • Probable serine carboxypeptidase CPVL (CPVL) in Oncology III panel - Q9H3G5
    • Probetacellulin (BTC) in Organ Damage panel - P35070
    • Procollagen C-endopeptidase enhancer 1 (PCOLCE) in Cardiometabolic panel - Q15113
    • Proepiregulin (EREG) in Neuro Exploratory panel - O14944
    • Programmed cell death 1 ligand 1 (PD-L1) in Inflammation panel - Q9NZQ7
    • Programmed cell death 1 ligand 1 (PD-L1) in Immuno-Oncology panel - Q9NZQ7
    • Programmed cell death 1 ligand 2 (PD-L2) in Cardiovascular II panel - Q9BQ51
    • Programmed cell death 1 ligand 2 (PD-L2) in Immuno-Oncology panel - Q9BQ51
    • Programmed cell death protein 1 (PDCD1) in Immuno-Oncology panel - Q15116
    • Programmed cell death protein 1 (PDCD1) in Organ Damage panel - Q15116
    • Proheparin-binding EGF-like growth factor (HB-EGF) in Cardiovascular II panel - Q99075
    • Prokineticin-1 (PROK1) in Cell Regulation panel - P58294
    • Prolactin regulatory element-binding protein (PREB) in Cell Regulation panel - Q9HCU5
    • Prolargin (PRELP) in Cardiovascular II panel - P51888
    • Proline-rich AKT1 substrate 1 (AKT1S1) in Neuro Exploratory panel - Q96B36
    • Prolow-density lipoprotein receptor-related protein 1 (LRP1) in Organ Damage panel - Q07954
    • Prolyl endopeptidase FAP (FAP) in Cardiometabolic panel - Q12884
    • Promotilin (MLN) in Oncology III panel - P12872
    • Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Cardiovascular III panel - Q8NBP7
    • Prostasin (PRSS8 ) in Cardiovascular II panel - Q16651
    • Proteasome activator complex subunit 1 (PSME1) in Neuro Exploratory panel - Q06323
    • Proteasome subunit alpha type-1 (PSMA1) in Organ Damage panel - P25786
    • Protein ABHD14B (ABHD14B) in Neuro Exploratory panel - Q96IU4
    • Protein AMBP (AMBP) in Cardiovascular II panel - P02760
    • Protein amnionless (AMN) in Organ Damage panel - Q9BXJ7
    • Protein BRICK1 (BRK1) in Oncology III panel - Q8WUW1
    • Protein canopy homolog 2 (CNPY2) in Oncology III panel - Q9Y2B0
    • Protein CYR61 (CYR61) in Oncology II panel - O00622
    • Protein deglycase DJ-1 (PARK7) in Development panel - Q99497
    • Protein delta homolog 1 (DLK-1) in Cardiovascular III panel - P80370
    • Protein disulfide-isomerase (P4HB) in Development panel - P07237
    • Protein enabled homolog (ENAH) in Organ Damage panel - Q8N8S7
    • Protein FAM19A5 (FAM19A5) in Cell Regulation panel - Q7Z5A7
    • Protein FAM3B (FAM3B) in Immune Response panel - P58499
    • Protein FAM3C (FAM3C) in Metabolism panel - Q92520
    • Protein fosB (FOSB) in Organ Damage panel - P53539
    • Protein HEXIM1 (HEXIM1) in Immune Response panel - O94992
    • Protein kinase C theta type (PRKCQ) in Immune Response panel - Q04759
    • Protein kinase C-binding protein NELL1 (NELL1) in Oncology III panel - Q92832
    • Protein max (MAX) in Organ Damage panel - P61244
    • Protein NDRG1 (NDRG1) in Neuro Exploratory panel - Q92597
    • Protein NOV homolog (NOV) in Development panel - P48745
    • Protein phosphatase 1B (PPM1B) in Organ Damage panel - O75688
    • Protein phosphatase inhibitor 2 (PPP1R2) in Metabolism panel - P41236
    • Protein S100-A11 (S100A11) in Oncology II panel - P31949
    • Protein S100-A12 (EN-RAGE ) in Inflammation panel - P80511
    • Protein S100-A16 (S100A16) in Oncology III panel - Q96FQ6
    • Protein S100-A4 (S100A4) in Oncology II panel - P26447
    • Protein S100-P (S100P) in Metabolism panel - P25815
    • Protein sprouty homolog 2 (SPRY2) in Immune Response panel - O43597
    • Protein tyrosine phosphatase type IVA 1 (PTP4A1) in Oncology III panel - Q93096
    • Protein Wnt-9a (WNT9A) in Cell Regulation panel - O14904
    • Protein XRP2 (RP2) in Oncology III panel - O75695
    • Protein-arginine deiminase type-2 (PADI2) in Immune Response panel - Q9Y2J8
    • Protein-glutamine gamma-glutamyltransferase 2 (TGM2) in Cardiovascular II panel - P21980
    • Proteinase-activated receptor 1 (PAR-1) in Cardiovascular II panel - P25116
    • Proto-oncogene tyrosine-protein kinase receptor Ret (RET) in Oncology II panel - P07949
    • Proto-oncogene tyrosine-protein kinase Src (SRC) in Cardiovascular II panel - P12931
    • Protocadherin-1 (PCDH1) in Oncology III panel - Q08174
    • Protocadherin-17 (PCDH17) in Cell Regulation panel - O14917
    • Protogenin (PRTG) in Neurology panel - Q2VWP7
    • Pulmonary surfactant-associated protein A1 (SFTPA1) in Oncology III panel - Q8IWL2
    • Pulmonary surfactant-associated protein D (PSP-D) in Cardiovascular III panel - P35247
    • R-spondin-1 (RSPO1) in Neurology panel - Q2MKA7
    • R-spondin-3 (RSPO3) in Oncology II panel - Q9BXY4
    • Ras association domain-containing protein 2 (RASSF2) in Organ Damage panel - P50749
    • Ras GTPase-activating protein 1 (RASA1) in Organ Damage panel - P20936
    • Ras GTPase-activating-like protein IQGAP2 (IQGAP2) in Cell Regulation panel - Q13576
    • Ras-related protein Rab-6A (RAB6A) in Oncology III panel - P20340
    • Receptor for advanced glycosylation end products (RAGE) in Cardiovascular II panel - Q15109
    • Receptor tyrosine-protein kinase erbB-2 (ErbB2/HER2) in Oncology II panel - P04626
    • Receptor tyrosine-protein kinase erbB-3 (ErbB3/HER3) in Oncology II panel - P21860
    • Receptor tyrosine-protein kinase erbB-4 (ErbB4/HER4) in Oncology II panel - Q15303
    • Receptor-type tyrosine-protein kinase FLT3 (FLT3) in Oncology III panel - P36888
    • Receptor-type tyrosine-protein phosphatase eta (PTPRJ) in Organ Damage panel - Q12913
    • Receptor-type tyrosine-protein phosphatase F (PTPRF) in Development panel - P10586
    • Receptor-type tyrosine-protein phosphatase mu (PTPRM) in Oncology III panel - P28827
    • Receptor-type tyrosine-protein phosphatase S (PTPRS) in Cardiometabolic panel - Q13332
    • Regenerating islet-derived protein 3-alpha (REG3A) in Cardiometabolic panel - Q06141
    • Regenerating islet-derived protein 4 (REG4) in Metabolism panel - Q9BYZ8
    • Regulator of G-protein signaling 8 (RGS8) in Cell Regulation panel - P57771
    • Renin (REN) in Cardiovascular II panel - P00797
    • Renin receptor (ATP6AP2) in Organ Damage panel - O75787
    • Repulsive guidance molecule A (RGMA) in Neurology panel - Q96B86
    • Resistin (RETN) in Cardiovascular III panel - Q9HD89
    • REST corepressor 1 (RCOR1) in Organ Damage panel - Q9UKL0
    • Reticulon-4 receptor (RTN4R) in Metabolism panel - Q9BZR6
    • Retinal dehydrogenase 1 (ALDH1A1) in Metabolism panel - P00352
    • Retinoic acid receptor responder protein 1 (RARRES1) in Organ Damage panel - P49788
    • Retinoic acid receptor responder protein 2 (RARRES2) in Cardiovascular III panel - Q99969
    • RGM domain family member B (RGMB) in Neurology panel - Q6NW40
    • Rho GTPase-activating protein 1 (ARHGAP1) in Cell Regulation panel - Q07960
    • Rho GTPase-activating protein 25 (ARHGAP25) in Oncology III panel - P42331
    • Rho guanine nucleotide exchange factor 12 (ARHGEF12) in Cell Regulation panel - Q9NZN5
    • Ribokinase (RBKS) in Neuro Exploratory panel - Q9H477
    • Ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) in Organ Damage panel - Q7LG56
    • Ribosomal protein S6 kinase beta-1 (RPS6KB1) in Neuro Exploratory panel - P23443
    • Ribosyldihydronicotinamide dehydrogenase [quinone] (NQO2) in Metabolism panel - P16083
    • RNA-binding protein FUS (FUS) in Oncology III panel - P35637
    • Roundabout homolog 1 (ROBO1) in Development panel - Q9Y6N7
    • Roundabout homolog 2 (ROBO2) in Neurology panel - Q9HCK4
    • Scavenger receptor class A member 5 (SCARA5) in Neurology panel - Q6ZMJ2
    • Scavenger receptor class F member 1 (SCARF1) in Development panel - Q14162
    • Scavenger receptor class F member 2 (SCARF2) in Neurology panel - Q96GP6
    • Scavenger receptor cysteine-rich domain-containing group B protein (SSC4D) in Metabolism panel - Q8WTU2
    • Scavenger receptor cysteine-rich type 1 protein M130 (CD163) in Cardiovascular III panel - Q86VB7
    • Sclerostin (SOST) in Metabolism panel - Q9BQB4
    • Secretagogin (SCGN) in Oncology III panel - O76038
    • Secreted frizzled-related protein 1 (SFRP1) in Neuro Exploratory panel - Q8N474
    • Secreted frizzled-related protein 3 (sFRP-3) in Neurology panel - Q92765
    • Secretoglobin family 3A member 2 (SCGB3A2) in Cardiovascular III panel - Q96PL1
    • Secretogranin-2 (SCG2) in Oncology III panel - P13521
    • Secretory carrier-associated membrane protein 3 (SCAMP3) in Oncology II panel - O14828
    • Seizure 6-like protein (SEZ6L) in Oncology II panel - Q9BYH1
    • Seizure 6-like protein 2 (SEZ6L2) in Cell Regulation panel - Q6UXD5
    • Selenocysteine lyase (SCLY) in Oncology III panel - Q96I15
    • Semaphorin-3F (SEMA3F) in Metabolism panel - Q13275
    • Semaphorin-4C (SEMA4C) in Cell Regulation panel - Q9C0C4
    • Semaphorin-7A (SEMA7A) in Development panel - O75326
    • Septin-9 (SEPT9) in Oncology III panel - Q9UHD8
    • Serine protease 27 (PRSS27) in Cardiovascular II panel - Q9BQR3
    • Serine protease HTRA2, mitochondrial (HTRA2) in Development panel - O43464
    • Serine protease inhibitor Kazal-type 1 (SPINK1) in Development panel - P00995
    • Serine protease inhibitor Kazal-type 4 (SPINK4) in Oncology III panel - O60575
    • Serine protease inhibitor Kazal-type 5 (SPINK5) in Development panel - Q9NQ38
    • Serine/threonine-protein kinase 4 (STK4) in Cardiovascular II panel - Q13043
    • Serine/threonine-protein kinase PAK 4 (PAK4) in Cell Regulation panel - O96013
    1. «
    2. 1
    3. 2
    4. 3
    5. 4
    6. 5
    7. 6
    8. 7
    9. »
  • Products – menu

    • Complete human protein biomarkers list
    • Cardiometabolic panel
    • Cell Regulation panel
    • Cardiovascular II panel
    • Cardiovascular III panel
    • Development panel
    • Immune Response panel
    • Immuno-Oncology panel
    • Inflammation panel
    • Metabolism panel
    • Neurology panel
    • Neuro Exploratory panel
    • Oncology II panel
    • Oncology III panel
    • Organ Damage panel
    • Olink Target 48 Cytokine
    • Mouse Exploratory panel
    • Insights Stat Analysis app
    • Custom panels
    • NPX Manager
    • Statistical services
    • Can we help you?
    • Let us know how best to contact you below (email or phone). PLEASE NOTE, include your international dialing code when submitting your phone number!

  • Follow us
    • 1506

    BIOMARKER ASSAYS

    • 193 778 000

    PROTEIN DATA POINTS GENERATED

    • 513

    PUBLICATIONS

Olink Essentials

  • Our Innovation

    Learn more about our technology and how it can meet your biomarker discovery needs

  • Our Products

    Learn more about our growing range of protein biomarker panels

  • Our Transparency

    Learn more about our rigorous assay QC and validation process and see the data

  • Our Expertise

    Learn more about Olink's Analysis Service: our in-house experts are here to run your assays for you

Do you want to know more?

Fill in the form and we will contact you as soon as we can.

Sitemap

  • Welcome to Olink
  • Products
  • Analysis Service
  • Data you can trust
  • Resources & support
  • About us

Contact

    • Email:
    • info@olink.com
    • Phone number:
    • +46 (0)18 - 444 39 70

Social media

  1. Copyright 2021 Olink
  2. Created with by wasabiweb
  • We use cookies to optimize your experience on our website. By choosing to continue, you acknowledge acceptance of our use of cookies. Learn more about cookies here.

  • Do not show this message again